These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
170 related items for PubMed ID: 3789729
1. Vanadyl (IV) and vanadate (V) binding to selected endogenous phosphate, carboxyl, and amino ligands; calculations of cellular vanadium species distribution. Nechay BR, Nanninga LB, Nechay PS. Arch Biochem Biophys; 1986 Nov 15; 251(1):128-38. PubMed ID: 3789729 [Abstract] [Full Text] [Related]
2. Mechanism of inhibition of glycolysis by vanadate. Benabe JE, Echegoyen LA, Pastrana B, Martínez-Maldonado M. J Biol Chem; 1987 Jul 15; 262(20):9555-60. PubMed ID: 3036865 [Abstract] [Full Text] [Related]
3. Vanadium: Risks and possible benefits in the light of a comprehensive overview of its pharmacotoxicological mechanisms and multi-applications with a summary of further research trends. Ścibior A, Pietrzyk Ł, Plewa Z, Skiba A. J Trace Elem Med Biol; 2020 Sep 15; 61():126508. PubMed ID: 32305626 [Abstract] [Full Text] [Related]
4. Generation of gas-phase VO2+, VOOH+, and VO2+-nitrile complex ions by electrospray ionization and collision-induced dissociation. Parsons Z, Leavitt C, Duong T, Groenewold GS, Gresham GL, Van Stipdonk MJ. J Phys Chem A; 2006 Oct 19; 110(41):11627-35. PubMed ID: 17034156 [Abstract] [Full Text] [Related]
5. Interaction of RNase A with VO3- and VO2+ ions. Metal ion binding mode and protein secondary structure. Purcell M, Novetta-Delen A, Arakawa H, Malonga H, Tajmir-Riahi HA. J Biomol Struct Dyn; 1999 Dec 19; 17(3):473-80. PubMed ID: 10636082 [Abstract] [Full Text] [Related]
6. The mechanism of vanadium action on selective K+-permeability in human erythrocytes. Fuhrmann GF, Hüttermann J, Knauf PA. Biochim Biophys Acta; 1984 Jan 11; 769(1):130-40. PubMed ID: 6419778 [Abstract] [Full Text] [Related]
7. Chelate antidotes for sodium vanadate and vanadyl sulfate intoxication in mice. Jones MM, Basinger MA. J Toxicol Environ Health; 1983 Jan 11; 12(4-6):749-56. PubMed ID: 6608005 [Abstract] [Full Text] [Related]
14. Reduction of [VO2(ma)2]- and [VO2(ema)2]- by ascorbic acid and glutathione: kinetic studies of pro-drugs for the enhancement of insulin action. Song B, Aebischer N, Orvig C. Inorg Chem; 2002 Mar 25; 41(6):1357-64. PubMed ID: 11896702 [Abstract] [Full Text] [Related]
15. Concerning the form of biochemically active vanadium. Rubinson KA. Proc R Soc Lond B Biol Sci; 1981 May 07; 212(1186):65-84. PubMed ID: 6115390 [Abstract] [Full Text] [Related]
16. Binding of vanadate to human serum transferrin. Harris WR, Carrano CJ. J Inorg Biochem; 1984 Nov 07; 22(3):201-18. PubMed ID: 6569067 [Abstract] [Full Text] [Related]
17. Superoxide-independent reduction of vanadate by rat liver microsomes/NAD(P)H: vanadate reductase activity. Shi X, Dalal NS. Arch Biochem Biophys; 1992 May 15; 295(1):70-5. PubMed ID: 1315507 [Abstract] [Full Text] [Related]
18. Vanadyl(IV) binding to mammalian ferritins. An EPR study aided by site-directed mutagenesis. Grady JK, Shao J, Arosio P, Santambrogio P, Chasteen ND. J Inorg Biochem; 2000 May 30; 80(1-2):107-13. PubMed ID: 10885470 [Abstract] [Full Text] [Related]
20. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals. Liboiron BD, Thompson KH, Hanson GR, Lam E, Aebischer N, Orvig C. J Am Chem Soc; 2005 Apr 13; 127(14):5104-15. PubMed ID: 15810845 [Abstract] [Full Text] [Related] Page: [Next] [New Search]